Carterra Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Carterra's estimated revenue is currently $11.5M per year.
- Carterra received $10.0M in venture funding in January 2018.
- Carterra's estimated revenue per employee is $212963
- Carterra's total funding is $25.5M.
- Carterra has 54 Employees.
- Carterra grew their employee count by 46% last year.
- Carterra currently has 2 job openings.
|Steve Chipchase||Vice President Operations|
|Tim Germann||Chief Commercial Officer|
|Chris Morrow||Director Of Engineering|
|Steve Wood||Director Of Manufacturing Operations|
|Tim Germann||Vice President, Global Sales and Service|
What Is Carterra?
Carterra, formerly Wasatch Microfluidics, develops high throughput surface plasmon resonance array-based platforms for biomolecular interaction analysis. Our new name is based on two core concepts: Cartography (mapping) and terra (worlds), literally meaning mapping worlds. This represents the Company's high-speed, high-resolution label-free biosensor technologies, which are being used by leading pharmaceutical and biotechnology companies to thoroughly explore their large monoclonal antibody (mAb) libraries to discover novel biotherapeutic candidates.keywords:Biotechnology,Healthcare
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Bristol-Meyers Squibb, Boehringer Ingelheim and Other Biotechnology Companies to Present Use of Carterra's Next Generation Antibody ...
Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a ...
Carterra® Inc., will host a series of symposia across the United States and Europe entitled, The therapeutic antibody revolution in the ...
|2018-01-18||$10.0M||Undisclosed||Telegraph Hill Partners||Article|